We are live on ! Find out more
NVCR icon

NovoCure

78 hedge funds and large institutions have $166M invested in NovoCure in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,711% more call options, than puts

Call options by funds: $4.49M | Put options by funds: $248K

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

164% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 11

24.32% more ownership

Funds ownership: 0%24.32% (+24%)

24% more funds holding

Funds holding: 6378 (+15)

3% more capital invested

Capital invested by funds: $161M → $166M (+$5.14M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
78
Holders Change
+15
Holders Change %
+23.81%
% of All Funds
1.95%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
22
Increased
29
Reduced
11
Closed
7
Calls
$4.49M
Puts
$248K
Net Calls
+$4.24M
Net Calls Change
+$2.28M

NVCR Hedge Fund Activity: Q4 2016 in Review

78 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2016, worth a combined $166M — up 3.2% from $161M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NVCR positions and 7 closed out — a net gain of 15 holders — while 29 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $11.4M. The largest seller was Deutsche Bank, cutting an estimated $1.87M.

  • 78 institutional investors held NovoCure (NVCR) as of Q4 2016, up from 63 in Q3 2016.
  • Funds reported $166M of NovoCure stock for Q4 2016, up 3.2% quarter-over-quarter.
  • 22 funds opened new NovoCure positions in Q4 2016 and 7 closed out, a net change of +15 holders.
  • The largest NovoCure buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $11.4M added.
  • The largest NovoCure seller in Q4 2016 was Deutsche Bank, an estimated $1.87M sold.

Based on aggregated 13F filings for Q4 2016.